Ophthalmology Market Research

Ophthalmology Market Research, Studies & Insights

Spherix Global Insights’ Ophthalmology therapeutic team is a leading provider of independent syndicated Ophthalmology market research, insights & business intelligence.

On an annual basis, Spherix’s Ophthalmology team publishes over 18 studies in three different indication areas including: diabetic retinopathy, diabetic macular edema and neovascular age-related macular degeneration.

Unparalleled Ophthalmology Therapeutic Expertise

Our team of ophthalmology experts delivers insights to pharmaceutical, life sciences, and biotechnology companies derived from ophthalmologists, healthcare providers & professionals, key opinion leaders, and the entire life sciences community. Insights from these experts help inform your product development and go-to-market strategies, helping you stay patient-focused at every step of the process.

Spherix Global Insights Ophthalmology – Your Trusted Advisor

Our clients are facing unprecedented challenges globally and must have the scientific, commercial, and operational capabilities necessary to thrive in an increasingly complex health care environment. As a trusted advisor, Spherix’s Ophthalmology syndicated market research studies empower our clients to innovate, thrive, and grow from development to launch.

Follow Spherix Ophthalmology on Social Media

Follow us for ophthalmology industry news, insights & analysis:

Twitter: https://twitter.com/SpherixOphtha 
LinkedIn: https://www.linkedin.com/company/spherix-global-insights/

For Guests & Current Clients

For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here:



Carl D. Regillo, MD, FACS


Carl D. Regillo, MD, FACS


Dr. Carl D. Regillo is the Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University in Philadelphia. He received his medical degree from Harvard Medical School and performed both his ophthalmology residency and vitreoretinal fellowship at Wills Eye Hospital. He is the founder and former Director of the Wills Eye Clinical Retina Research Unit, former Chairman of the American Academy of Ophthalmology Retina Basic and Clinical Science Course, former Chairman of the Wills Eye Institutional Review Board, and prior Director of the Wills Eye Retina Fellowship. He has authored over 200 publications along with over 20 book chapters and nine major books. He has been an investigator on numerous major clinical trials developing new treatments for retinal disorders such as macular degeneration and diabetic retinopathy. He lectures worldwide. He has served on the scientific editorial board for the American Journal of Ophthalmology, Review of Ophthalmology, Current Opinion in Ophthalmology, Yearbook of Ophthalmology, Retinal Physician, and Retina Today. He is a recipient of the American Academy of Ophthalmology Achievement, Senior Achievement, Secretariat, and Lifetime Achievement Awards along with the American Society of Retina Specialists Honor, Senior Honor, and Founders Awards. He was named one of the “150 Top Innovators in Retina” by Ocular Surgery News, selected a Charter Inductee of the Retina Hall of Fame in 2017, and on the Ophthalmology Power List 2018 and 2020 of the top 100 most influential people in the world of ophthalmology. He has been listed multiple times through the years as a retina “Top Doctor” in the Philadelphia Magazine, Philadelphia Life, Mainline Today, and South Jersey Magazine. He was also listed among the top 150 ophthalmologists in the US by Newsweek in 2021.

Judy E. Kim, MD


Judy E. Kim, MD


Judy E. Kim, MD is an internationally well-known vitreoretinal specialist, who is a Professor of Ophthalmology and Visual Sciences with tenure, Professor of the Graduate School of Biomedical Sciences, and Director of Teleophthalmology and Research at the Medical College of Wisconsin (MCW). She is a graduate of the University of Chicago and Johns Hopkins University School of Medicine. She completed her ophthalmology residency at the Bascom Palmer Eye Institute of the University of Miami and vitreoretinal surgical and medical fellowship at MCW and was a Howard Hughes-NIH Research Scholar. Having immigrated from S. Korea, she has been a trail blazer in ophthalmology, including becoming the second Korean-American to achieve the rank of professor of ophthalmology in the United States and receiving the Distinguished Asian Professional Award. She has held leadership positions in numerous major ophthalmology organizations, including Board of Trustee of American Academy of Ophthalmology (AAO), the executive committees of American Society of Retina Specialists (ASRS), Macula Society, Diabetic Retinopathy Clinical Research Retina network (DRCR.net), Women in Retina, NAEVR/AEVR, an advocacy group for eye research funding, and on the editorial board of JAMA Ophthalmology. Dr. Kim will become only the second woman to be the president of ASRS, the largest retina society in the world. Dr. Kim has received numerous awards and honors for her clinical excellence, leadership, and service to organizations, including Achievement Award, Senior Achievement Award, and Lifetime Achievement Award from AAO, Honor Award and Senior Honor Award from ASRS, Fellow of ARVO, and has been included in the Castle Connolly Top Doctor list, US News and World Reports Best Doctors and in the Best Doctor’s List continuously for over two decades. She has been selected to the “2021 Power List” of most influential ophthalmologists around the world by the Ophthalmologists, “150 Innovators” list from Ocular Surgery News and is an inaugural member of the “Retina Hall of Fame”. She has published over 200 papers and given over 400 presentations, including over 150 invited national and international presentations and named lectures. She has been actively involved with over 70 multicenter clinical trials, serving on multiple roles including as a principal investigator, sub-investigator, committees on protocol design, quality control, writing, and data safety and monitoring board. She has been a leader in diabetic retinopathy research, including leading a national study, and has served as a vice-chair of DRCR.net, which is a leading research organization supported by the NIH on diabetic retinopathy and other retinal diseases. In addition to diabetic retinopathy, her research interests include age-related macular degeneration, surgical retina, telemedicine, ocular imaging, and community engaged research. She aspires to improve people’s lives through providing compassionate and excellent patient care, furthering science and innovation, mentoring of the next generation, service to professional organizations, and promoting health and gender equity.

Related Content


Get more information on Spherix's Ophthalmology Coverage